Skip to main content
SLU:s publikationsdatabas (SLUpub)

Sammanfattning

After comparing the morbidity patterns of COVID-19 infections, variations of oxytocin levels and some properties of the neurohormone oxytocin, the authors put forward their hypothesis that oxytocin might constitute a safe, inexpensive and readily available treatment for this disease.

Nyckelord

COVID-19; pandemic; treatment; oxytocin; immune system; inflammation

Publicerad i

Clinical Neuropsychiatry
2020, volym: 17, nummer: 3, sidor: 192-195

SLU författare

Globala målen (SDG)

SDG3 God hälsa och välbefinnande

UKÄ forskningsämne

Farmakologi och toxikologi

Publikationens identifierare

  • DOI: https://doi.org/10.36131/CNEPUB20201703

Permanent länk till denna sida (URI)

https://res.slu.se/id/publ/106969